Literature DB >> 14586798

Factors influencing metacarpal bone mineral density in adults with cerebral palsy.

Hiroyuki Nakano1, Kiyoshi Aoyagi, Shohei Ohgi, Tomitaro Akiyama.   

Abstract

Several studies have examined bone mineral density (BMD) and related factors in children with cerebral palsy, but there are no such studies of adults with cerebral palsy. We evaluated BMD in 123 institutionalized adults (51 men aged 21-41 years and 72 premenopausal women aged 24-46 years) with cerebral palsy, and examined the associations of BMD with mobility level, use of anticonvulsant drugs, and abnormal calcium metabolism status. Hand radiographs were used to measure BMD of the second metacarpal bone (mBMD). Body weight (kg), height (m), and body mass index (BMI) were recorded. Serum calcium, phosphate, and alkaline phosphatase were measured. Abnormal calcium metabolism, defined as calcium <8.5 mg/dl, phosphate <2.6 mg/dl, or alkaline phosphatase >260 U/l, was identified in 28% of the men and 31% of the women. Multiple regression analysis showed that the use of anticonvulsant drugs was significantly associated with lower mBMD in both sexes. Higher alkaline phosphatase level was significantly associated with lower mBMD in men. Mobility level (ambulation) was significantly associated with higher mBMD in women. Neither age nor BMI correlated with mBMD. Our findings indicated poor bone health status in adults with cerebral palsy and the existence of several factors that could affect bone metabolism in these patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586798     DOI: 10.1007/s00774-003-0436-4

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  2 in total

1.  Osteoporosis in adults with cerebral palsy: feasibility of DXA screening and risk factors for low bone density.

Authors:  C Marciniak; J Gabet; J Lee; M Ma; K Brander; N Wysocki
Journal:  Osteoporos Int       Date:  2015-11-17       Impact factor: 4.507

2.  Aging and bone health in individuals with developmental disabilities.

Authors:  Joan Jasien; Caitlin M Daimon; Stuart Maudsley; Bruce K Shapiro; Bronwen Martin
Journal:  Int J Endocrinol       Date:  2012-07-22       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.